Givaudan stock weighs growth against lower first-half profit

Published on 09/28/2026 at 16:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Givaudan stock traded at CHF 3,429.00 on September 28, 2026, down 0.52 percent on SIX. First-half sales rose 3.6 percent like for like, but net income fell to CHF 475 million.

Givaudan CH0010645932 fotorealistisches Parfumeur-Atelier mit Reagenzgläsern, getrockneten Blüten und warmem goldenem Nachmittagslicht, Illustration mit AI erstellt.

Givaudan stock (ISIN CH0010645932) was trading at CHF 3,429.00 on SIX at 4:23 p.m. CEST on September 28, 2026, down 0.52 percent from the prior close. The latest half-year figures combine 3.6 percent like-for-like sales growth with a 19.8 percent fall in net income.

Sales growth stays positive

According to Givaudan in its half-year release dated July 23, 2026, group sales for the first six months reached CHF 3,799 million. Like-for-like growth was 3.6 percent, while sales in Swiss francs declined 1.7 percent because of currency effects.

Fragrance and Beauty generated CHF 2,010 million, up 6.5 percent like for like. Taste and Wellbeing contributed CHF 1,789 million, with like-for-like growth of 0.5 percent, leaving the two divisions with a wide performance gap.

Profitability is the key counterweight

The same Givaudan release reported adjusted EBITDA of CHF 923 million and an adjusted EBITDA margin of 24.3 percent, compared with 25.2 percent in the first half of 2025. Reported EBITDA fell to CHF 820 million from CHF 945 million.

Net income was CHF 475 million, compared with CHF 592 million a year earlier, and the net profit margin declined to 12.5 percent from 15.3 percent. Givaudan also reported adjusted basic earnings per share of CHF 60.25, down from CHF 66.71 in the prior-year period.

Stock remains below the yearly high

The share price stood CHF 163.00 below the 52-week high of CHF 3,592.00 and CHF 863.00 above the 52-week low of CHF 2,566.00 on September 28, 2026. Market capitalization was CHF 31.7 billion, while reported trading volume stood at 4,768 shares.

For investors, the next measurable checkpoint is the company's nine-month sales report scheduled for October 13, 2026, after an investor field trip on September 29 and September 30, according to Givaudan. The contrast between positive underlying sales growth and lower reported profitability defines the stock's current setup.